CA-A Cancer Journal for Clinicians

Article	Citations
Breast cancer in a transgender man	20641
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey	13228
Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates	7973
Minority groups underrepresented in hematologic cancer trials	2668
Cancer treatment and survivorship statistics, 2025	2334
Near majority of adults favor R ratings for films with smoking	1694
Issue Information	561
	365
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians	291
	257
Correction to “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline”	240
Correction to “Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases”	218
Screening for colorectal cancer	187
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer	183
Colorectal cancer statistics, 2026	146
Cancer statistics 2024: All hands on deck	135
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types	116
Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision‐making	113
Blood tests for colorectal cancer—Hype ahead of evidence?	109
Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer	101
Most patients with cancer are not undergoing germline genetic testing	98
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies	93
Multicancer detection tests: What we know and what we don’t know	93
Cancer statistics, 2026	86
Reviewer acknowledgement 2025	84

	77
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach	75
	74
Issue Information	70
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine	68
More care needed for cancer caregivers	65
The evolving landscape of tissue‐agnostic therapies in precision oncology	61
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review	53
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial	52
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future	51
Medicaid expansion increases survival for patients with cancer	48
Study identifies risk factors that may lead to secondary cancers	47
Does distance deter male fertility preservation?	44
Lung cancer screening guidelines: Smoking matters, not quitting	43
Overlooked barriers to implementation of geriatric assessment	40
Study assesses normal tissue effects after axillary radiotherapy for early breast cancer	39
Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review	34
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma	29
Interventional gastroenterology in oncology	29
Accurate data as the foundation of equitable cancer control: Lessons from global cancer statistics 2024 and the complexity of ovarian cancer	29
The contemporary management of cancers of the sinonasal tract in adults	28
Colorectal cancer screening: An update to the American Cancer Society guideline, 2026	28
Prostate cancer statistics, 2025	24
Cancer survivors at greater risk for bone fractures late in life	23
Issue Information	23
From medical student to Editor: A note of thanks	22
Issue Information	21
Screening for lung cancer	21
Bilateral mastectomy may not reduce mortality risk	21
Issue Information	21
Twenty‐year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation i	20
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance	19
Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline	19
Breast Cancer Statistics, 2022	18
Chemotherapy‐induced taste changes affect nutrition, quality of life	18
Serious mental illness and cancer: A call to action for equitable care	18
Issue Information	15
Is active surveillance an alternative to surgery for some patients with esophageal cancer?	14
Prevention of device‐related infections in patients with cancer: Current practice and future horizons	14
	14
	13
Issue Information	12
Better communication is key for quality‐of‐life improvement in low‐income and minority patients	11
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors	11
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries	11
Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer	10
Key issues face AI deployment in cancer care	10
Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma	10
	10
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer	10

Cancer misinformation on social media	10
Global cancer statistics for children: Two decades of change and projections to 2050	9
	9
Social determinants of health and US cancer screening interventions: A systematic review	9
	8
Issue Information	8
Urothelial carcinoma: Perioperative considerations from top to bottom	8
Radiotheranostics in oncology: Making precision medicine possible	7
Geriatric assessment for the practicing clinician: The why, what, and how	7
Carcinoma of unknown primary: Molecular tumor board‐based therapy	7
Global cancer statistics: A healthy population relies on population health	7
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer	7
Correction to “Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs”	6
Smoking cessation support lags behind lung cancer screenings	6
	5
Is mandated genetic counseling needed?	5
Reviewer acknowledgement 2022	5
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?	4
Cancer disparities for LGBTQ+ patients identified more fully	4
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer	4
Fertility counseling for reproductive‐age women with cancer should address gestational carriers	4
Cancer statistics for A merican I ndian and A l	4
Issue Information	4
Issue Information	4
The evolving landscape of salivary gland tumors	4
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial	3
Issue Information	3
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates	3
Study identifies signs and symptoms of colorectal cancer risk at younger ages	3
Regorafenib as maintenance therapy showed significant delayed progression of non‐adipocytic soft tissue sarcomas	3
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer	3
Sustained weight loss may reduce cancer risk	3
	2
	2
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy	2
Erratum to “Cancer statistics, 2024”	2
Erectile dysfunction common within the first year after rectal cancer surgery	2
Correction to “Serious mental illness and cancer: A call to action for equitable care”	2
Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025	2
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians	2
A patient with newly diagnosed breast cancer found to have mosaic TP53 likely pathogenic variant	2
Issue Information	2
Issue Information	2
	2
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management	2
Data support longer recurrence‐free survival with nivolumab than with ipilimumab for stage III or IV melanoma	2
Update and new advances in fertility preservation and cancer	2
Learning from prostate cancer statistics	1
Reviewer acknowledgement 2023	1
Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer	1
People experiencing homelessness face inpatient care disparities	1
Immunosurveillance in clinical cancer management	1
Cancer in rural America: Improving access to clinical trials and quality of oncologic care	1
Cancer statistics, 2026: Charting a course for a national cancer research agenda	1
Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐dri	1
Colon cancer blood test effective for average‐risk population	1
Issue Information	1
Cancer care for people with dementia: Literature overview and recommendations for practice and research	1
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries	1
Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack‐year history: A systematic review	1
Colonoscopies for patients aged 45–49 years yield positive results	1
Clinician communication strategies associated with increased uptake of the human papillomavirus ( HPV ) vaccine: A systematic review	1
	1
Most young female cancer survivors are at minimal risk for obstetric problems	1
Correction to “American Cancer Society’s report on the status of cancer disparities in the United States, 2025”	1
	1
Cancer statistics for African American and Black people, 2025	1
Nonpharmacologic interventions for managing distress, anxiety, and depression for patients with cancer and their family caregivers: A systematic review and meta‐analysis	1
Issue Information	1
Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape	1
Extranodal natural killer/T‐cell lymphoma: From fatal to curable	1
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019	1
Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022	1
Cancer statistics, 2025	1
Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification	1
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature	1
MCED blood test boosts cancer detection in symptomatic patients	1
Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology	1
Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?	1
Correction to “Cancer treatment and survivorship statistics, 2025”	1

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

1